Datametrex AI Limited (DTMXF) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Datametrex AI Limited (DTMXF) opera en el sector Technology, cotizado por última vez a $ con una capitalización de mercado de 0. Calificado con 39/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 17 mar 2026Perfil Tecnológico y Posición Competitiva de Datametrex AI Limited (DTMXF)
Datametrex AI Limited provides AI-powered data analytics and health security solutions, operating primarily in Canada and South Korea. The company leverages machine learning for data collection, analysis, and presentation, serving industries through its AI and Technology, and Health Security segments. It faces competition in the rapidly evolving AI and health tech landscape.
Tesis de Inversión
Datametrex AI Limited presents a speculative investment opportunity within the AI and health security sectors. The company's negative profit margin of -114.8% indicates it is not currently profitable. Revenue growth and market expansion, particularly in the health security segment, are key value drivers. Successful adoption of its Medi-Call app and NexaSecurity platform could drive future growth. However, the company's small market capitalization and OTC listing introduce significant risk. The investment thesis hinges on Datametrex's ability to scale its AI solutions and achieve profitability in a competitive market. Investors should closely monitor financial performance and market traction.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $0.00B indicates a micro-cap company with high growth potential but also significant risk.
- Negative P/E ratio of -0.74 reflects current unprofitability, requiring careful monitoring of future earnings.
- Gross margin of -13.4% suggests challenges in cost management and pricing strategy.
- Beta of 1.26 indicates higher volatility compared to the market, appealing to risk-tolerant investors.
- Operations in both Canada and South Korea provide geographic diversification and exposure to different market dynamics.
Competidores y Pares
Fortalezas
- Patented AI technology provides a competitive edge.
- Diversified service offerings across AI, technology, and health security.
- Presence in both Canada and South Korea offers geographic diversification.
- Proprietary NexaSecurity platform provides specialized social media monitoring capabilities.
Debilidades
- Negative profit margin indicates financial instability.
- Small market capitalization increases volatility and risk.
- Reliance on COVID-19 related services may decline as the pandemic subsides.
- Limited brand recognition compared to larger competitors.
Catalizadores
- Upcoming: Potential partnerships with healthcare providers to expand Medi-Call adoption.
- Ongoing: Increasing demand for AI-driven data analytics solutions in various sectors.
- Ongoing: Expansion of NexaSecurity platform to new industries and clients.
Riesgos
- Potential: Intense competition from larger AI and IT service providers.
- Potential: Rapid technological advancements may render existing solutions obsolete.
- Ongoing: Negative profit margin indicates financial instability.
- Ongoing: OTC listing and small market capitalization increase volatility and risk.
- Potential: Regulatory changes in the healthcare and data privacy sectors.
Oportunidades de crecimiento
- Expansion of Medi-Call App: The Medi-Call health app represents a significant growth opportunity for Datametrex. As telemedicine gains wider acceptance, the company can leverage this platform to connect more patients with doctors, offering subscription-based e-health services. The global telemedicine market is projected to reach $431.82 billion by 2030, growing at a CAGR of 25.9% from 2023. Successful marketing and adoption of Medi-Call could drive recurring revenue and establish Datametrex as a key player in the digital health space.
- NexaSecurity Platform Adoption: Datametrex's NexaSecurity platform offers social media discovery and monitoring capabilities. With increasing concerns about online security and misinformation, demand for social media monitoring tools is growing. The social media analytics market is expected to reach $16.55 billion by 2030, growing at a CAGR of 17.2%. By enhancing the platform's features and targeting specific industries, Datametrex can capitalize on this trend and generate revenue through subscriptions and customized solutions.
- AI-Driven Data Analytics Services: Datametrex's core strength lies in its AI-driven data analytics capabilities. As businesses generate vast amounts of data, the need for AI-powered solutions to extract insights and improve decision-making is increasing. The global big data and analytics market is projected to reach $549.7 billion by 2028, growing at a CAGR of 13.2%. Datametrex can focus on specific sectors, such as healthcare and finance, to provide tailored data analytics services and secure long-term contracts.
- Strategic Partnerships: Forming strategic partnerships with established companies in the technology and healthcare sectors can accelerate Datametrex's growth. Collaborating with larger firms can provide access to new markets, technologies, and customer bases. For example, partnering with a major hospital network could facilitate the adoption of Medi-Call and other health security services. These partnerships can enhance Datametrex's credibility and expand its reach.
- Geographic Expansion: While Datametrex currently operates in Canada and South Korea, expanding into new geographic markets represents a significant growth opportunity. Targeting regions with high demand for AI solutions and telemedicine services can diversify revenue streams and reduce reliance on existing markets. Conducting market research and establishing local partnerships are crucial for successful geographic expansion. This could include entering the US or European markets.
Oportunidades
- Expansion of telemedicine services through the Medi-Call app.
- Growing demand for AI-driven data analytics solutions.
- Strategic partnerships with established companies in the technology and healthcare sectors.
- Geographic expansion into new markets with high demand for AI and telemedicine.
Amenazas
- Intense competition from larger and better-funded AI and IT service providers.
- Rapid technological advancements may render existing solutions obsolete.
- Regulatory changes in the healthcare and data privacy sectors.
- Economic downturns may reduce demand for AI and technology services.
Ventajas competitivas
- Patented machine learning and artificial intelligence technology.
- Diversified service portfolio across AI, technology, and health security.
- Established presence in both Canada and South Korea.
- Proprietary NexaSecurity social media monitoring platform.
Acerca de DTMXF
Datametrex AI Limited, headquartered in Toronto, Canada, specializes in collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence. The company was founded to leverage AI for diverse applications, evolving into two primary segments: AI and Technology, and Health Security. The AI and Technology segment focuses on providing big data analytics and system integration services. The Health Security segment offers COVID-19 related services, concierge medical services, and telemedicine solutions. Datametrex offers a range of products including NexaSecurity, a social media monitoring platform, and Medi-Call, a health app connecting patients with doctors for e-health services. The company also sells COVID-19 test kits. Datametrex operates primarily in Canada and South Korea, aiming to expand its AI-driven solutions across various sectors. Its competitive positioning relies on patented AI technology and a diversified service portfolio, addressing both technological and health-related needs.
Qué hacen
- Collects and analyzes structured and unstructured data.
- Develops and applies machine learning and artificial intelligence solutions.
- Offers health security services, including COVID-19 related services.
- Provides concierge medical services and telemedicine solutions.
- Sells COVID-19 test kits.
- Offers NexaSecurity, a social-media discovery and monitoring platform.
- Provides Medi-Call health app, connecting patients with doctors.
Modelo de Negocio
- Provides AI and Technology solutions, generating revenue through contracts and service fees.
- Offers Health Security services, earning revenue through service fees and product sales.
- Sells subscriptions to the Medi-Call health app.
- Generates revenue from the NexaSecurity platform through subscriptions and customized solutions.
Contexto de la Industria
Datametrex AI Limited operates within the rapidly evolving AI and information technology services industry. The market is characterized by increasing demand for data analytics, machine learning solutions, and telemedicine services. Competition includes established IT service providers and specialized AI firms. Datametrex's focus on both AI and health security positions it uniquely, but it faces challenges in scaling and competing with larger, better-funded players. The industry is driven by technological advancements, regulatory changes, and the increasing adoption of digital health solutions.
Clientes Clave
- Businesses seeking AI-driven data analytics solutions.
- Healthcare providers and patients utilizing telemedicine services.
- Organizations requiring social media monitoring and security solutions.
- Government agencies needing data analysis and security services.
Finanzas
Gráfico e información
Precio de la acción de Datametrex AI Limited (DTMXF): Price data unavailable
Últimas noticias
-
Datametrex Subsidiary PayMetrex Highlights Strategic Relevance of Patent Portfolio to Rapidly Expanding SoftPOS Market
accessnewswire.com · 19 mar 2026
-
Datametrex Integrates AI to Healthcare To Enhance Efficiencies
accessnewswire.com · 10 mar 2026
-
Paymetrex Engages Pelent AI to Accelerate Patent Licensing Program
accessnewswire.com · 23 feb 2026
-
Datametrex Receives $1M Order from Fortune 500 Client
accessnewswire.com · 18 feb 2026
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para DTMXF.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para DTMXF.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de DTMXF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Últimas Noticias
Datametrex Subsidiary PayMetrex Highlights Strategic Relevance of Patent Portfolio to Rapidly Expanding SoftPOS Market
Datametrex Integrates AI to Healthcare To Enhance Efficiencies
Paymetrex Engages Pelent AI to Accelerate Patent Licensing Program
Datametrex Receives $1M Order from Fortune 500 Client
Liderazgo: Dong Hyun Shim
CEO
Dong Hyun Shim serves as the CEO of Datametrex AI Limited, leading a team of 21 employees. Information regarding his detailed career history, educational background, and previous roles is not available. His leadership is focused on guiding the company's strategic direction in the AI, technology, and health security sectors. He is responsible for overseeing the development and implementation of Datametrex's AI-driven solutions and expanding its market presence in Canada and South Korea.
Historial: Due to limited information, specific achievements, strategic decisions, and company milestones under Dong Hyun Shim's leadership cannot be detailed. His tenure and impact on Datametrex's performance require further assessment based on available financial reports and company announcements.
Información del mercado OTC de DTMXF
The OTC Other tier represents the lowest tier of the OTC market, indicating that Datametrex AI Limited may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be current in their reporting obligations. Investing in OTC Other stocks carries significant risks due to the potential for lack of transparency and regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. This tier is also known as the Pink Open Market.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure increases the risk of investing in DTMXF.
- Low liquidity can make it difficult to buy or sell shares at desired prices.
- Higher price volatility due to the OTC listing and small market capitalization.
- Potential for fraud or manipulation due to less regulatory oversight.
- OTC Other tier status indicates the company may not meet minimum financial standards.
- Verify the company's financial reporting status and access available financial statements.
- Assess the trading volume and bid-ask spread to understand liquidity risks.
- Research the company's management team and their track record.
- Review the company's filings and disclosures on the OTC Markets website.
- Consult with a financial advisor to assess the risks and suitability of investing in DTMXF.
- Understand the company's business model and competitive landscape.
- Confirm the legitimacy of the company's operations and assets.
- Operations in Canada and South Korea suggest established business activities.
- Patented AI technology indicates innovation and intellectual property.
- Presence of a CEO and management team suggests organizational structure.
- Provision of health security services indicates engagement with regulated industries.
Lo Que los Inversores Preguntan Sobre Datametrex AI Limited (DTMXF)
¿Cuáles son los factores clave para evaluar DTMXF?
Datametrex AI Limited (DTMXF) actualmente tiene una puntuación IA de 39/100, indicando puntuación baja. Fortaleza clave: Patented AI technology provides a competitive edge.. Riesgo principal a monitorear: Potential: Intense competition from larger AI and IT service providers.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de DTMXF?
DTMXF actualmente puntúa 39/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de DTMXF?
Los precios de DTMXF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre DTMXF?
La cobertura de analistas para DTMXF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en DTMXF?
Las categorías de riesgo para DTMXF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Intense competition from larger AI and IT service providers.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de DTMXF?
La relación P/E para DTMXF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está DTMXF sobrevalorada o infravalorada?
Determinar si Datametrex AI Limited (DTMXF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de DTMXF?
Datametrex AI Limited (DTMXF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Limited information available on CEO track record.
- Lack of analyst coverage impacts investment thesis validation.
- OTC market carries inherent risks due to limited regulation and disclosure.